ERα, a key target for cancer therapy: A review
Y Liu, H Ma, J Yao - OncoTargets and therapy, 2020 - Taylor & Francis
Estrogen receptor α (ERα) is closely associated with both hormone-dependent and hormone-
independent tumors, and it is also essential for the development of these cancers. The …
independent tumors, and it is also essential for the development of these cancers. The …
Implications of estrogen and its receptors in colorectal carcinoma
Estrogens have been implicated in the pathogenesis of various cancer types, including
colorectal carcinoma (CRC). Estrogen receptors such as ERα and ERβ activate intracellular …
colorectal carcinoma (CRC). Estrogen receptors such as ERα and ERβ activate intracellular …
Immunoglobulin‑like transcript 4 and human leukocyte antigen‑G interaction promotes the progression of human colorectal cancer
Z Cai, L Wang, Y Han, W Gao… - International …, 2019 - spandidos-publications.com
Abstract Immunoglobulin‑like transcript (ILT) 4, a negative regulator of immune response in
allograft rejection, autoimmunity and infectious diseases, has recently been determined to …
allograft rejection, autoimmunity and infectious diseases, has recently been determined to …
Estrogen-related receptor alpha (ERRα) is a key regulator of intestinal homeostasis and protects against colitis
The estrogen-related receptor alpha (ERRα) is a primary regulator of mitochondrial energy
metabolism, function and dynamics, and has been implicated in autophagy and immune …
metabolism, function and dynamics, and has been implicated in autophagy and immune …
Potential health risk of endocrine disruptors in construction sector and plastics industry: a new paradigm in occupational health
Endocrine disruptors (EDs) belong to large and diverse groups of agents that may cause
multiple biological effects associated with, for example, hormone imbalance and infertility …
multiple biological effects associated with, for example, hormone imbalance and infertility …
The emerging role of estrogen related receptorα in complications of non‑small cell lung cancers
TK Mukherjee, P Malik, JR Hoidal - Oncology Letters, 2021 - spandidos-publications.com
Approximately 85% of lung cancer cases are recognized as non‑small cell lung cancer
(NSCLC) with a perilous (13‑17%) 5‑year survival in Europe and the USA. Although tobacco …
(NSCLC) with a perilous (13‑17%) 5‑year survival in Europe and the USA. Although tobacco …
Estrogen-related receptor alpha in select host functions and cancer: new frontiers
HS Ranhotra - Molecular and Cellular Biochemistry, 2022 - Springer
Eukaryotic gene expression is under the tight control of transcription factors, which includes
the estrogen-related receptor alpha (ERRα). The endogenous ligand (s) acting as ERRα …
the estrogen-related receptor alpha (ERRα). The endogenous ligand (s) acting as ERRα …
Combined estrogen alpha and beta receptor expression has a prognostic significance for colorectal cancer patients
We reported that high estrogen receptor beta (ERβ) expression is independently associated
with better prognosis in female colorectal cancer (CRC) patients. However, estrogen …
with better prognosis in female colorectal cancer (CRC) patients. However, estrogen …
High dual expression of the biomarkers CD44v6/α2β1 and CD44v6/PD-L1 indicate early recurrence after colorectal hepatic metastasectomy
F Wrana, K Dötzer, M Prüfer, J Werner, B Mayer - Cancers, 2022 - mdpi.com
Simple Summary Distant metastasis in colorectal cancer still correlates with poor prognosis,
emphasizing the high need for new diagnostic and therapeutic strategies. In the present …
emphasizing the high need for new diagnostic and therapeutic strategies. In the present …
Sexual dimorphism in colorectal cancer: molecular mechanisms and treatment strategies
Y Rodríguez-Santiago, CA Garay-Canales… - Biology of Sex …, 2024 - Springer
Introduction Sexual dimorphism significantly influences cancer incidence and prognosis.
Notably, females exhibit a lower risk and favorable prognosis for non-reproductive cancers …
Notably, females exhibit a lower risk and favorable prognosis for non-reproductive cancers …